Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · IEX Real-Time Price · USD
17.33
-0.05 (-0.29%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Avadel Pharmaceuticals Market Cap
Avadel Pharmaceuticals has a market cap or net worth of $1.57 billion as of April 19, 2024. Its market cap has increased by 149.95% in one year.
Market Cap
1.57B
Enterprise Value
1.50B
1-Year Change
149.95%
Ranking
Category
Stock Price
$17.33
Market Cap Chart
Since December 31, 2002, Avadel Pharmaceuticals's market cap has increased from $70.50M to $1.57B, an increase of 2,126.52%. That is a compound annual growth rate of 15.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 1.57B | -3.39% |
Apr 17, 2024 | 1.63B | -0.55% |
Apr 16, 2024 | 1.64B | 6.41% |
Apr 15, 2024 | 1.54B | 6.32% |
Apr 12, 2024 | 1.45B | 0.19% |
Apr 11, 2024 | 1.45B | -1.18% |
Apr 10, 2024 | 1.46B | -3.70% |
Apr 9, 2024 | 1.52B | -2.10% |
Apr 8, 2024 | 1.55B | 2.64% |
Apr 5, 2024 | 1.51B | 0.60% |
Apr 4, 2024 | 1.50B | 1.84% |
Apr 3, 2024 | 1.48B | -0.73% |
Apr 2, 2024 | 1.49B | -1.50% |
Apr 1, 2024 | 1.51B | -1.36% |
Mar 28, 2024 | 1.53B | 0.30% |
Mar 27, 2024 | 1.53B | 3.69% |
Mar 26, 2024 | 1.47B | -2.11% |
Mar 25, 2024 | 1.50B | -3.65% |
Mar 22, 2024 | 1.56B | 0.76% |
Mar 21, 2024 | 1.55B | 3.14% |
Mar 20, 2024 | 1.50B | 4.88% |
Mar 19, 2024 | 1.43B | 0.19% |
Mar 18, 2024 | 1.43B | -0.94% |
Mar 15, 2024 | 1.44B | -1.12% |
Mar 14, 2024 | 1.46B | 0.12% |
View and export this data all the way back to 2002.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Twist Bioscience | 1.62B |
Recursion Pharmaceuticals | 1.60B |
Taro Pharmaceutical Industries | 1.59B |
Supernus Pharmaceuticals | 1.58B |
Addus HomeCare | 1.58B |
Ardelyx | 1.50B |
Dynavax Technologies | 1.48B |
Protagonist Therapeutics | 1.47B |